PT1333841E - Chaperonina 10 de m. tuberculosis e suas utilizacoes - Google Patents
Chaperonina 10 de m. tuberculosis e suas utilizacoesInfo
- Publication number
- PT1333841E PT1333841E PT01983701T PT01983701T PT1333841E PT 1333841 E PT1333841 E PT 1333841E PT 01983701 T PT01983701 T PT 01983701T PT 01983701 T PT01983701 T PT 01983701T PT 1333841 E PT1333841 E PT 1333841E
- Authority
- PT
- Portugal
- Prior art keywords
- tuberculosis
- chaperonine
- 60kda
- autoimmune
- approx
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0028122.0A GB0028122D0 (en) | 2000-11-17 | 2000-11-17 | Method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1333841E true PT1333841E (pt) | 2006-10-31 |
Family
ID=9903393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01983701T PT1333841E (pt) | 2000-11-17 | 2001-11-16 | Chaperonina 10 de m. tuberculosis e suas utilizacoes |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20040127438A1 (pt) |
| EP (3) | EP1333841B1 (pt) |
| JP (5) | JP2004525085A (pt) |
| AT (2) | ATE355845T1 (pt) |
| AU (5) | AU1511702A (pt) |
| CA (2) | CA2429897A1 (pt) |
| CY (2) | CY1105619T1 (pt) |
| DE (2) | DE60127159D1 (pt) |
| DK (1) | DK1333841T3 (pt) |
| ES (2) | ES2585641T3 (pt) |
| GB (3) | GB0028122D0 (pt) |
| HK (2) | HK1060970A1 (pt) |
| NZ (2) | NZ525858A (pt) |
| PT (1) | PT1333841E (pt) |
| WO (3) | WO2002040517A2 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0028122D0 (en) * | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
| AU2002952492A0 (en) | 2002-11-06 | 2002-11-21 | Cbio Limited | Chaperonin 10 immunosuppression |
| AU2003277992B2 (en) * | 2002-11-06 | 2008-07-10 | Cbio Limited | Chaperonin 10 immunosuppression |
| GB0226105D0 (en) * | 2002-11-08 | 2002-12-18 | St Georges S Entpr Ltd | Pain relief agents |
| NZ548985A (en) * | 2004-01-16 | 2010-02-26 | Cbio Ltd | Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion |
| EP1951282A4 (en) * | 2005-10-20 | 2009-09-02 | Cbio Ltd | TREATMENT OF HYPERSENSITIVITY |
| AU2013205017B2 (en) * | 2006-03-02 | 2014-05-01 | Cbio Limited | Regulation of immune responses by modulation of the function of antigen presenting cells |
| CA2644058C (en) * | 2006-03-02 | 2016-08-09 | Cbio Limited | Regulation of immune responses by modulation of the function of antigen presenting cells |
| US8834895B2 (en) * | 2007-03-21 | 2014-09-16 | National Research Council Of Canada | Use of Francisella tularensis for prevention and treatment of allergic airway disorders |
| GB0803369D0 (en) | 2008-02-25 | 2008-04-02 | Helperby Therapeutics Ltd | Biological materials and uses thereof |
| GB201118201D0 (en) | 2011-10-21 | 2011-12-07 | Helperby Therapeutics Ltd | Novel peptides |
| CN106581672A (zh) * | 2015-10-15 | 2017-04-26 | 广东思峰生物科技有限责任公司 | 一种rhIL‑12用于治疗非活动性乙肝的药物组合物 |
| CN107202894B (zh) * | 2016-03-17 | 2019-02-22 | 广东体必康生物科技有限公司 | Rv1078蛋白在诊断潜伏性/活动性肺结核中的用途 |
| GB201700557D0 (en) | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Novel peptides |
| GB201700555D0 (en) * | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Method for the treatment of a relapsing-remitting condition |
| IL314861A (en) | 2022-02-17 | 2024-10-01 | Revolo Biotherapeutics Ltd | A method for the production of a peptide derived from chaperonin 60.1 |
| WO2023223015A1 (en) | 2022-05-16 | 2023-11-23 | Revolo Biotherapeutics Limited | Methods and compositions for preventing or treating food allergies |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5780034A (en) * | 1989-03-14 | 1998-07-14 | Yeda Research And Development Co. Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents |
| CA2176948C (en) * | 1993-11-30 | 2007-05-15 | Halle Morton | Chaperonin 10 |
| PT731811E (pt) * | 1993-11-30 | 2005-04-29 | Univ Queensland | Chaperonina 10 |
| CA2185826C (en) * | 1994-03-21 | 2007-06-19 | Stephen Mark Anderton | Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| IT1271074B (it) * | 1994-11-21 | 1997-05-26 | Italfarmaco Spa | Peptidi ad attivita' antiinfiammatoria |
| CA2272536A1 (en) * | 1996-11-26 | 1998-06-04 | Stressgen Biotechnologies Corp. | Immune responses using compositions containing stress proteins |
| FR2766191B1 (fr) * | 1997-07-21 | 2000-11-10 | Ifremer | Peptides anti-microbiens de crustaces |
| CA2315880A1 (en) * | 1997-12-31 | 1999-07-15 | Stressgen Biotechnologies Corporation | Streptococcal heat shock proteins of the hsp60 family |
| EP1049483A1 (en) * | 1998-01-23 | 2000-11-08 | National Jewish Medical and Research Center | Method for treating inflammatory diseases using heat shock proteins |
| IL126447A (en) * | 1998-10-04 | 2004-09-27 | Vascular Biogenics Ltd | An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis |
| DE69929454T2 (de) * | 1998-11-05 | 2006-09-28 | Hadasit Medical Research Services & Development Co. Ltd. | Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen |
| EP1196772A2 (en) * | 1999-07-08 | 2002-04-17 | Stressgen Biotechnologies Corporation | Induction of a th1-like response in vitro |
| GB0028122D0 (en) * | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
-
2000
- 2000-11-17 GB GBGB0028122.0A patent/GB0028122D0/en not_active Ceased
-
2001
- 2001-11-16 DK DK01983701T patent/DK1333841T3/da active
- 2001-11-16 JP JP2002542410A patent/JP2004525085A/ja active Pending
- 2001-11-16 US US10/416,884 patent/US20040127438A1/en not_active Abandoned
- 2001-11-16 PT PT01983701T patent/PT1333841E/pt unknown
- 2001-11-16 EP EP01983701A patent/EP1333841B1/en not_active Expired - Lifetime
- 2001-11-16 JP JP2002542409A patent/JP4890733B2/ja not_active Expired - Fee Related
- 2001-11-16 EP EP05077510.5A patent/EP1693068B1/en not_active Expired - Lifetime
- 2001-11-16 DE DE60127159T patent/DE60127159D1/de not_active Expired - Lifetime
- 2001-11-16 AT AT01983694T patent/ATE355845T1/de not_active IP Right Cessation
- 2001-11-16 AU AU1511702A patent/AU1511702A/xx active Pending
- 2001-11-16 GB GB0311383A patent/GB2389852B/en not_active Expired - Lifetime
- 2001-11-16 NZ NZ525858A patent/NZ525858A/en not_active IP Right Cessation
- 2001-11-16 AU AU1512302A patent/AU1512302A/xx active Pending
- 2001-11-16 WO PCT/GB2001/005066 patent/WO2002040517A2/en not_active Application Discontinuation
- 2001-11-16 CA CA002429897A patent/CA2429897A1/en not_active Abandoned
- 2001-11-16 AU AU2002215117A patent/AU2002215117B2/en not_active Ceased
- 2001-11-16 CA CA002429894A patent/CA2429894A1/en not_active Abandoned
- 2001-11-16 ES ES05077510.5T patent/ES2585641T3/es not_active Expired - Lifetime
- 2001-11-16 NZ NZ525859A patent/NZ525859A/en unknown
- 2001-11-16 AU AU2002215123A patent/AU2002215123B2/en not_active Ceased
- 2001-11-16 ES ES01983701T patent/ES2267836T3/es not_active Expired - Lifetime
- 2001-11-16 WO PCT/GB2001/005069 patent/WO2002040037A2/en active IP Right Grant
- 2001-11-16 GB GB0311389A patent/GB2390366B/en not_active Expired - Fee Related
- 2001-11-16 EP EP01983694A patent/EP1333840B9/en not_active Expired - Lifetime
- 2001-11-16 US US10/432,054 patent/US20040132163A1/en not_active Abandoned
- 2001-11-16 DE DE60119959T patent/DE60119959T2/de not_active Expired - Lifetime
- 2001-11-16 WO PCT/GB2001/005084 patent/WO2002040038A2/en active IP Right Grant
- 2001-11-16 AT AT01983701T patent/ATE326977T1/de active
- 2001-11-16 AU AU2002223817A patent/AU2002223817A1/en not_active Abandoned
-
2004
- 2004-05-12 HK HK04103315A patent/HK1060970A1/xx not_active IP Right Cessation
- 2004-05-20 HK HK04103573A patent/HK1060521A1/xx not_active IP Right Cessation
-
2006
- 2006-06-19 CY CY20061100817T patent/CY1105619T1/el unknown
-
2007
- 2007-03-16 CY CY20071100376T patent/CY1106394T1/el unknown
-
2008
- 2008-02-19 JP JP2008037217A patent/JP4648955B2/ja not_active Expired - Lifetime
- 2008-02-19 JP JP2008037290A patent/JP2008174565A/ja active Pending
- 2008-02-19 JP JP2008037550A patent/JP4648956B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106394T1 (el) | Χαπepονινη 60.1 m.tuberculosis και χρησεις αυτης | |
| ATE532860T1 (de) | B7-ähnliche moleküle und deren anwendungen | |
| DK1465626T3 (da) | Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf | |
| WO2003101401A3 (en) | Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer | |
| DE602004023725D1 (de) | Muteine von tränen-lipocalin | |
| EP2769715A3 (en) | Methods for treating autoimmune disorders, and reagents related thereto | |
| BR0211200A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
| DE60138715D1 (de) | Tnf-rezeptor-ähnliche moleküle und deren anwendungen | |
| ATE326981T1 (de) | Isolierte peptide die aminosäuresequenzen von ny- eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen | |
| DE60037978D1 (de) | Interferon ähnliche moleküle, und deren verwendungen | |
| MXPA03010728A (es) | Moleculas de proteina-2 relacionadas con b7 y uso de las mismas. | |
| ATE360076T1 (de) | Alkalische ceramidase (e.c. 3.5.1.23) kodierendes gen aus pseudomonas aeruginosa | |
| WO2002072632A3 (en) | Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. | |
| WO2003025014A3 (fr) | Utilisation de peptides comportant des modifications de type post-traductionnel dans le cadre du traitement de pathologies auto-immunes | |
| ATE230027T1 (de) | Menschliche dnase i varianten | |
| WO2002033058A3 (en) | Novel cysteine proteases and uses thereof | |
| DE60022069D1 (de) | Nicht-anaphylaktische formen des grasspollenallergens ph1 p 6 und deren verwendung | |
| WO2002062845A3 (en) | Adhesion molecules | |
| AU2002350406A1 (en) | Identification of ses-3 (spr-5) in c. elegans and the uses of the same | |
| WO2002062976A3 (en) | Serine proteases |